GT Biopharma ($GTBP) CEO on FDA Approval for New Investigational Drug Trial for Solid Tumor Cancer скачать в хорошем качестве

GT Biopharma ($GTBP) CEO on FDA Approval for New Investigational Drug Trial for Solid Tumor Cancer

This interview is disseminated on behalf of GT Biopharma. GT Biopharma (NASDAQ: GTBP) recently received approval from the U.S. Food and Drug Administration (FDA) for a new investigational drug trial for the solid tumor cancer treatment GTB-3650, as the race to develop a cure for cancer intensifies and the solid tumor market grows to $362 billion. Executive Chairman and Chief Executive Officer Michael Breen shares more details about the company’s expectations and success indicators for the basket trial of the new medication, as well as upcoming milestones for 2026. Explore GT Biopharma: https://www.gtbiopharma.com/ 00:00 Introduction 00:29 Investigational Drug Trial for New Cancer Treatment 01:55 Basket Trial: Targeting Deadly, Prolific Solid Tumor Cancers 04:46 Functional Parts of the New Cancer Treatment 06:05 Expectations for the Phase I Drug Trial 08:09 Success Indicators and Signs for the Drug Trial: Safety, Efficacy, Etc. 09:57 Solid Tumor Cancer Market: $362B Yearly Worldwide 12:04 Increasing Drug Potency with Nanobody Technology, Molecule Changes 15:13 GT Biopharma Milestones for 2026: Blood Cancer Drug Progress, Data, Etc. Past videos:    • GT Biopharma ($GTBP) CEO on Expanding Into...      • Advancing Humane Cancer Therapy: GT Biopha...      • GT Biopharma ($GTBP) CEO on TriKE®️ Platfo...   #Oncology #CancerTreatment #SolidTumor #BloodCancer #DrugTrial #Biopharmacy #Cancer #Exploration #Biotech #Investors #StockstoWatch #GTBiopharma ➡️ Check out https://StockTA.com for FREE Stock Technical Analysis and Trading Tools to make smarter investment decisions. FOLLOW STOCKS TO WATCH ON: X: https://x.com/stocks2watch_ TikTok:   / globalonemedia   Spotify: https://open.spotify.com/show/6VzOJFG... ________________ DISCLAIMER: The content presented on Stocks To Watch is for informational and educational purposes only and should not be construed as financial, investment, legal, tax, or any other professional advice. Nothing in this video or its accompanying materials constitutes a recommendation, endorsement, solicitation, or offer to buy or sell any securities or to pursue any investment strategy. Viewer discretion is advised, as investments discussed on this channel — particularly in early-stage, junior, exploration, or emerging sectors — carry a high degree of risk and may result in the loss of your entire investment. You should never invest money you cannot afford to lose and are strongly encouraged to conduct your own independent research and consult with a licensed financial professional before making any investment decisions. Stocks To Watch is operated by Global One Media Group Pte. Ltd. (https://globalonemedia.com), which may receive compensation from companies featured in this video in connection with media creation, corporate communications, digital distribution, and investor awareness efforts. Such compensation may be provided in cash or in securities, including shares, options, or warrants. All interviews on Stocks To Watch are unscripted. The views and statements expressed belong solely to the individuals appearing in the video and do not necessarily reflect the views of Stocks To Watch or Global One Media. Global One Media, its directors, employees, contractors, and guests may hold, buy, or sell securities of companies featured on Stocks To Watch at any time. They are under no obligation to disclose or update their holdings, and viewers should assume that Global One Media and its affiliates may have a financial interest in the companies discussed. While reasonable efforts are made to ensure that the information shared on Stocks To Watch is accurate and current, no guarantee is made as to its completeness, reliability, or suitability. The content may include forward-looking statements that involve assumptions, risks, and uncertainties which may cause actual results to differ materially. Stocks To Watch and Global One Media are not registered as securities broker-dealers, investment advisers, or accountants in any jurisdiction and do not provide personalized investment recommendations, suitability assessments, or financial planning services. By watching this video, you acknowledge and agree that Global One Media operates under the laws of Singapore and that you are responsible for complying with the laws of your own jurisdiction. Global One Media disclaims all liability for any direct or consequential loss arising from reliance on any information presented.